Clinical effectiveness of nirmatrelvir plus ritonavir in patients with COVID‐19 and substance use disorders based on real‐world data

TH Liu, PY Huang, JY Wu, MH Chuang… - Journal of Medical …, 2023 - Wiley Online Library
This study assessed the clinical efficacy of nirmatrelvir plus ritonavir (NMV‐r) in treating
patients with coronavirus disease‐2019 (COVID‐19) and substance use disorders (SUDs) …
被引用次数：9 相关文章

Clinical effectiveness of nirmatrelvir plus ritonavir in patients with COVID‐19 and substance use disorders based on real‐world data.

TH Liu, PY Huang, JY Wu, MH Chuang… - Journal of Medical …, 2023 - search.ebscohost.com
This study assessed the clinical efficacy of nirmatrelvir plus ritonavir (NMV‐r) in treating
patients with coronavirus disease‐2019 (COVID‐19) and substance use disorders (SUDs) …

Clinical effectiveness of nirmatrelvir plus ritonavir in patients with COVID-19 and substance use disorders based on real-world data

TH Liu, PY Huang, JY Wu… - Journal of medical …, 2023 - pubmed.ncbi.nlm.nih.gov
This study assessed the clinical efficacy of nirmatrelvir plus ritonavir (NMV-r) in treating
patients with coronavirus disease-2019 (COVID-19) and substance use disorders (SUDs) …

Clinical effectiveness of nirmatrelvir plus ritonavir in patients with COVID-19 and substance use disorders based on real-world data.

TH Liu, PY Huang, JY Wu, MH Chuang… - Journal of Medical …, 2023 - europepmc.org
This study assessed the clinical efficacy of nirmatrelvir plus ritonavir (NMV-r) in treating
patients with coronavirus disease-2019 (COVID-19) and substance use disorders (SUDs) …